Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Leukocytapheresis in rheumatoid arthritis.
Hidaka T, Hashiba Y, Kubo K, Kai Y, Maeda K. Hidaka T, et al. Among authors: hashiba y. Transfus Apher Sci. 2017 Oct;56(5):698-702. doi: 10.1016/j.transci.2017.08.017. Epub 2017 Aug 30. Transfus Apher Sci. 2017. PMID: 28918917 Review.
Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
Mori S, Yoshitama T, Hidaka T, Sakai F, Hasegawa M, Hashiba Y, Suematsu E, Tatsukawa H, Mizokami A, Yoshizawa S, Hirakata N, Ueki Y. Mori S, et al. Among authors: hashiba y. PLoS One. 2017 Jun 8;12(6):e0179179. doi: 10.1371/journal.pone.0179179. eCollection 2017. PLoS One. 2017. PMID: 28594905 Free PMC article.
The time-sequential changes of risk factors for adult T-cell leukemia development in human T-cell leukemia virus-positive patients with rheumatoid arthritis: a retrospective cohort study.
Umekita K, Hashiba Y, Kariya Y, Kubo K, Miyauchi S, Aizawa A, Umeki K, Nomura H, Kawaguchi T, Matsuda M, Takajo I, Hidaka T, Okayama A. Umekita K, et al. Among authors: hashiba y. Mod Rheumatol. 2019 Sep;29(5):795-801. doi: 10.1080/14397595.2018.1519890. Epub 2018 Oct 25. Mod Rheumatol. 2019. PMID: 30246572
Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
Umekita K, Hashiba Y, Iwao K, Iwao C, Kimura M, Kariya Y, Kubo K, Miyauchi S, Kudou R, Rikitake Y, Takajo K, Kawaguchi T, Matsuda M, Takajo I, Inoue E, Hidaka T, Okayama A. Umekita K, et al. Among authors: hashiba y. PLoS One. 2020 May 27;15(5):e0233159. doi: 10.1371/journal.pone.0233159. eCollection 2020. PLoS One. 2020. PMID: 32459801 Free PMC article. Clinical Trial.
Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritis.
Endo Y, Fukui S, Umekita K, Suzuki T, Miyamoto J, Morimoto S, Shimizu T, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Okada A, Fujikawa K, Mizokami A, Matsuoka N, Aramaki T, Ueki Y, Eguchi K, Kariya Y, Hashiba Y, Hidaka T, Okayama A, Kawakami A, Nakamura H. Endo Y, et al. Among authors: hashiba y. Mod Rheumatol. 2021 Sep;31(5):972-978. doi: 10.1080/14397595.2020.1847802. Epub 2020 Nov 27. Mod Rheumatol. 2021. PMID: 33161771
HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study.
Umekita K, Hashikura Y, Takaki A, Kimura M, Kawano K, Iwao C, Miyauchi S, Kawaguchi T, Matsuda M, Hashiba Y, Hidaka T. Umekita K, et al. Among authors: hashiba y. Viruses. 2023 Feb 8;15(2):468. doi: 10.3390/v15020468. Viruses. 2023. PMID: 36851682 Free PMC article.
77 results